All peptide stacks
Cognition · Stress · Mood

Semax + Selank Stack

A Russian-developed nootropic and anxiolytic peptide pairing — researched for combined cognitive performance and stress-resilience effects.

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Why these two are stacked

Semax (an ACTH 4-10 fragment) is researched for BDNF and NGF upregulation, dopaminergic modulation, and neuroprotection — typically framed as cognitive performance and focus. Selank (a tuftsin-derived heptapeptide) modulates GABA and serotonin signaling and is researched as an anxiolytic without sedation or tolerance. Combined, the pair is studied where users want stress reduction without the cognitive blunting that benzodiazepine-class anxiolytics produce.

Both peptides are delivered intranasally and act centrally. Semax leans glutamatergic and dopaminergic; selank leans GABAergic and serotonergic. The non-overlapping mechanisms are why the pair is researched together rather than substituted for each other.

Researched together for

  • BDNF and NGF upregulation (semax)
  • Anxiolytic effects without sedation (selank)
  • Stress-induced cognitive performance preservation
  • Mood regulation in chronic stress models
  • Neuroprotection in stroke / ischemia research

Sample weekly schedule

WhenResearch protocol
AM · semaxIntranasal semax (research dose typically 300–600 mcg) on waking.
Midday · selankIntranasal selank (research dose typically 250–500 mcg) midday or before stressful work blocks.
Cycle lengthResearch cycles run 10–14 days, often repeated with 1–2 week breaks; longer continuous use is less studied.

Timing notes

  • Semax is most often dosed in the morning to align with cognitive performance windows.
  • Selank can be used acutely for stress events or scheduled midday; effects are typically felt within 15–30 minutes.
  • Spray volumes and concentrations vary widely between research suppliers — verify mcg per spray before dosing.

Stack-specific considerations

  • Neither peptide is FDA-approved; both are Russian-developed research peptides.
  • Long-term safety data in Western populations is limited.
  • Intranasal irritation, mild headache, or sedation (selank) are commonly noted.
  • Avoid combining with prescription anxiolytics or stimulants without physician supervision.

Frequently asked

Q.Can semax and selank be taken on the same day?

Yes — most research protocols use them on the same day, with semax in the AM and selank later. They act on largely non-overlapping pathways.

Q.Will selank cause sedation like a benzodiazepine?

Research suggests selank has anxiolytic effects without the sedation or motor impairment of benzodiazepines, and without tolerance with intermittent use.

Q.Is the stack addictive?

Neither peptide has demonstrated dependence or withdrawal in published research, though long-term data is limited.

Q.How fast do effects appear?

Acute effects are often reported within 15–30 minutes of intranasal dosing; cumulative effects on mood and cognition build over 1–2 weeks.

Q.Can I use them long-term?

Published research focuses on 10–14 day cycles. Continuous long-term use is not well-studied; intermittent cycling is the conservative approach.

Q.Are oral or injectable versions effective?

Both peptides are typically researched intranasally because nasal mucosa delivery bypasses first-pass metabolism. Oral peptide is degraded; injectable is rarely used in human research.

Q.Can this stack replace SSRIs or stimulants?

No. Neither peptide is FDA-approved for mood or attention disorders, and they should not replace prescribed medication without physician guidance.